Kimberly Kraig Thompson - 24 May 2022 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
CEO & CFO, Director, 10%+ Owner
Signature
/s/ Kim Thompson
Issuer symbol
KBLB
Transactions as of
24 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 16:30:54 UTC
Previous filing
25 May 2022
Next filing
01 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KBLB Common Stock Sale -30,000 -0.01% 202,794,824 24 May 2022 Direct F1, F4
transaction KBLB Common Stock Sale -25,000 -0.01% 202,769,824 25 May 2022 Direct F2, F4
transaction KBLB Common Stock Sale -10,000 -0% 202,759,824 26 May 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on May 24, 2022 at $0.069.
F2 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on May 25, 2022 at $0.069.
F3 These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on May 26, 2022 at $0.07.
F4 Includes 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson, and the remainder consists of common stock Mr. Thompson owns.